Clinical Trials in Foley, Alabama

Find clinical trials in Foley, Alabama. Discover local research opportunities and treatment options in your area.

8 Active Trials Found in Foley

Showing 8 trials on this page

Page 1 of 1

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

NCT ID: NCT06504446

This clinical trial is studying a new treatment called NOC-110 for adults who suffer from a persistent cough that lasts for more than a year and doesn't have a clear cause. The goal is to see if th...

Recruiting

Phase: PHASE2 Conditions: Refractory or Unexplained Chronic Cough

Registry of the Patient Experience for Carpal Tunnel Release

NCT ID: NCT06071468

This clinical trial, called the Registry of the Patient Experience for Carpal Tunnel Release, is studying the experiences of patients who are planning to have surgery for Carpal Tunnel Syndrome (CT...

Recruiting

Conditions: Carpal Tunnel Syndrome, CTS

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT ID: NCT07000357

This clinical trial is studying a medication called AZD0780 to see if it can help reduce serious heart-related events in patients who have a history of cardiovascular disease or are at high risk fo...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Disease

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD

NCT ID: NCT06883305

This clinical trial is investigating the effectiveness and safety of a medication called Tezepelumab for adults with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD). COPD is a ...

Recruiting

Phase: PHASE3 Conditions: Chronic Obstructive Pulmonary Disease (COPD)

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

NCT ID: NCT06899217

This clinical trial is investigating a new medication called CIN-102 (deudomperidone) to see if it can help reduce nausea in adults with idiopathic gastroparesis, a condition that affects how the s...

Recruiting

Phase: PHASE2 Conditions: Idiopathic Gastroparesis

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

NCT ID: NCT05905926

This is an open-label, long-term safety study of tenapanor (also called Ibsrela) for children and teens with Irritable Bowel Syndrome with Constipation (IBS-C). The study will look mainly at safety...

Enrolling by invitation

Phase: PHASE3 Conditions: Irritable Bowel Syndrome With Constipation (IBS-C)

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

NCT ID: NCT04636814

This clinical trial, known as the PILLAR study, is looking at the effectiveness and safety of a new medication called CHF6001 (also known as Tanimilast) when added to existing treatments for people...

Recruiting

Phase: PHASE3 Conditions: Chronic Obstructive Pulmonary Disease

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

NCT ID: NCT05643534

This clinical trial is studying a new treatment called tenapanor for young people aged 12 to under 18 years who have Irritable Bowel Syndrome with Constipation (IBS-C). The main goal is to see if t...

Recruiting

Phase: PHASE3 Conditions: Irritable Bowel Syndrome With Constipation (IBS-C)

Search All Trials Browse All Locations